Expo News Today — July 25, 2026

As we begin the day, several key developments are unfolding across the healthcare, technology, and financial sectors. In the healthcare space, FDA advisers have given the green light for the compounding of six popular peptides, a decision that comes after careful consideration of various issues. Meanwhile, a massive cyclospora outbreak has now spread to nine states, according to the CDC, highlighting the ongoing challenges in public health. In the tech world, NVIDIA's CEO Jensen Huang is urging AI policymakers to take a thoughtful approach, emphasizing the high stakes involved in shaping the future of artificial intelligence.

In the financial markets, investors are weighing their options in response to recent earnings reports and stock movements. While some analysts are advising to buy the dip in Intel's stock, they are more cautious about the prospects of Dover's bounce. SAP's strong revenue has led to a rise in its stock, although analysts are warning about potential risks related to the company's guidance. These developments serve as a reminder of the complex interplay between technology, healthcare, and finance, and the need for informed decision-making in both personal and professional contexts, as illustrated by the difficult choices individuals may face, such as navigating sensitive family matters like inheritance.

Today's signal:
• FDA advisers say six popular peptides can be compounded. Here are the issues they considered. (marketwatch.com)
• Jensen Huang has a high-stakes message for AI policymakers (marketwatch.com)
• Why we would buy the Intel dip but can't get behind the Dover bounce (cnbc.com)
• CDC says massive cyclospora outbreak is now in nine states (cnbc.com)
• SAP’s stock rises on strong revenue, but analysts warn of guidance risks (marketwatch.com)
• ‘It’s nothing personal’: Should I tell my 96-year-old stepmother that I don’t want her inheritance? (marketwatch.com)